Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease

Status:
Completed

Trial end date:
2011-10-01

Target enrollment:

Participant gender:

Investigate the Safety and Efficacy of Two Concentrations of DE-110 Compared to Placebo for the Treatment of Dry Eye Disease

Phase 2

Santen Inc.